Article
Asiatic Acid from Centella asiatica as a Potent EGFR Tyrosine Kinase Inhibitor with Anticancer Activity in NSCLC Cells Harboring Wild-Type and T790M-Mutated EGFR.
Biomolecules - 3 Oct 2025
Monmai Chaiwat, Sabuakham Sahachai, Pabuprapap Wachirachai, Chaichompoo Waraluck, Suksamrarn Apichart, Mahalapbutr Panupong
Abstract excerpt
Lung cancer is a leading cause of cancer mortality worldwide. Targeted therapies with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) represent a significant advance in the management of lung cancer. However, their long-term efficacy is often limited by acquired resistance, particularly due to the T790M mutation, highlighting the need for novel EGFR-TKIs. Although compounds derived from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
